Answers are grounded in this paper and cite their sources.
Despite strong evidence for its clinical effectiveness, the global rollout of supervised injectable opioid treatment (SIOT) remains limited. This paper reports on the first SIOT intervention trialled in Australia. Drawing on in-depth interviews conducted with trial staff (n = 10), our analysis focuses on the process of implementing a complex intervention within a complex local setting. What happens when a new treatment technology (SIOT using injectable hydromorphone) is implemented within an established opioid agonist treatment (OAT) service? What key challenges emerged in the process? Our approach draws on a seminal implementation science framework, the Consolidated Framework for Implementation Research (CFIR). Following the CFIR, the primary focus of our analysis is the trial's 'Inner Setting', comprising three interactive layers: the (trial) SIOT clinic, the OAT service, and the inner-city hospital accommodating both. Several key challenges were identified, including reports of ideological tensions between trial and existing OAT staff regarding SIOT as a 'legitimate' treatment option; concerns regarding governance, leadership and accountability; calls for more training and support to address the skills and complexities of SIOT nursing; and the constraints associated with aspects of the physical infrastructure of the trial, such as the waiting room shared between trial participants and regular OAT clients. A future scale-up of SIOT in Australia that is both sustainable and accessible will depend on its integration within the existing public OAT infrastructure. Our findings identify some of the important preparatory work, including supporting cultural change and clinical readiness within the OAT workforce, required to ensure a successful integration.
No takes yet. Share an insight, caveat, or question.
Rance et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: